Skip to main content
PCRX
NASDAQ Life Sciences

Pacira's Gene Therapy PCRX-201 Hits Manufacturing Milestone, ASCEND Data Due Year-End

Tom Rudovsky · Reported by Reuters
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$26
Mkt Cap
$1.018B
52W Low
$18.8
52W High
$27.64
52W Position info
38% above low
Off High info
5.9% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

PCRX sits 38% above its 52-week low of $18.8.

Summary

Pacira's gene therapy candidate PCRX-201 has successfully transitioned to a scalable commercial manufacturing process, a critical step toward potential commercialization. The Part A enrollment in the ASCEND study is now complete, with topline data expected by the end of 2026. This progress comes amid a heated proxy battle with activist investor DOMA Perpetual, where the company's pipeline execution is a central point of contention. The manufacturing milestone de-risks the program and strengthens management's hand ahead of the shareholder vote. The upcoming ASCEND data readout will be a major catalyst for the stock.

At the time of this announcement, PCRX was trading at $26.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1B. The 52-week trading range was $18.80 to $27.64. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

PCRX - Latest Insights

PCRX
Nov 17, 2026, 8:50 AM EST
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $36.49
Real-time Price: $36.49 info
Change: $0 (0%) info
Market Cap: $1.463B info
PCRX
Nov 12, 2026, 4:20 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $36.46
Real-time Price: $36.49 info
Change: +$0.030 (+0.08%) info
Market Cap: $1.463B info
PCRX
Nov 12, 2026, 4:15 PM EST
Filing Type: SC 14D9/A
Importance Score:
7
Price at Filing: $36.46
Real-time Price: $36.49 info
Change: +$0.030 (+0.08%) info
Market Cap: $1.463B info
PCRX
Nov 05, 2026, 4:37 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $36.42
Real-time Price: $36.49 info
Change: +$0.070 (+0.19%) info
Market Cap: $1.463B info
PCRX
Nov 05, 2026, 4:33 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $36.42
Real-time Price: $36.49 info
Change: +$0.070 (+0.19%) info
Market Cap: $1.463B info